Advisor OS LLC reduced its stake in Danaher Co. (NYSE:DHR – Free Report) by 51.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,883 shares of the conglomerate’s stock after selling 6,240 shares during the quarter. Advisor OS LLC’s holdings in Danaher were worth $1,350,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also bought and sold shares of the company. Cutter & CO Brokerage Inc. raised its position in shares of Danaher by 3.1% during the 4th quarter. Cutter & CO Brokerage Inc. now owns 2,217 shares of the conglomerate’s stock valued at $509,000 after buying an additional 66 shares in the last quarter. Lake Street Advisors Group LLC increased its stake in Danaher by 1.2% in the fourth quarter. Lake Street Advisors Group LLC now owns 5,967 shares of the conglomerate’s stock valued at $1,371,000 after acquiring an additional 71 shares during the last quarter. JFG Wealth Management LLC purchased a new stake in Danaher during the fourth quarter valued at about $315,000. Bradley & Co. Private Wealth Management LLC bought a new stake in Danaher during the fourth quarter worth about $64,000. Finally, FFT Wealth Management LLC boosted its holdings in shares of Danaher by 25.8% in the 4th quarter. FFT Wealth Management LLC now owns 3,300 shares of the conglomerate’s stock worth $758,000 after purchasing an additional 676 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 11.10% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on DHR
Danaher Stock Performance
Shares of DHR stock opened at $210.65 on Wednesday. The firm has a market capitalization of $150.56 billion, a price-to-earnings ratio of 39.90, a PEG ratio of 2.66 and a beta of 0.83. The stock has a fifty day moving average of $225.79 and a 200 day moving average of $246.04. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the business posted $2.09 earnings per share. As a group, research analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is presently 24.24%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- Investing in Construction Stocks
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Are Penny Stocks a Good Fit for Your Portfolio?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- What is the Hang Seng index?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.